Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,021.00
+13.35 (1.32%)
Apr 29, 2026, 12:19 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 123.68 billion as of April 28, 2026. Its market cap has decreased by -5.27% in one year.
Market Cap
123.68B
Enterprise Value
117.75B
Revenue
25.12B
Ranking
n/a
PE Ratio
22.78
Stock Price
1,021.00
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 123.68B, an increase of 34.85%. That is a compound annual growth rate of 6.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 128.25B | 14.05% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alembic Pharmaceuticals | 150.29B |
| Strides Pharma Science | 101.26B |
| Cohance Lifesciences | 165.31B |
| Eris Lifesciences | 188.17B |
| NATCO Pharma | 195.21B |
| Akums Drugs and Pharmaceuticals | 81.34B |
| Sudeep Pharma | 76.70B |
| Piramal Pharma | 224.11B |